)
Arcadia Biosciences (RKDA) investor relations material
Arcadia Biosciences Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Focuses on science-based consumer goods, currently offering Zola™ coconut water products with various flavors and Non-GMO certification.
Transitioned from crop improvement and trait licensing to consumer hydration products after divesting wheat and related assets in 2024.
Retains certain rights to previously sold crop traits and has entered into agreements to transfer or acquire specific agricultural intellectual property.
Financial performance and metrics
Received $4.0 million from the sale of a wheat trait and $3.7 million from the sale of the Good Wheat™ brand in 2024.
Raised approximately $2.1 million in gross proceeds from the exercise of investment options in January 2026.
Faces recurring net losses, accumulated deficit, and insufficient resources to meet anticipated cash requirements, raising substantial doubt about ability to continue as a going concern.
Use of proceeds and capital allocation
Will not receive proceeds from stockholder resales; proceeds from option exercises (up to $3.94 million if fully exercised) are intended for working capital and general corporate purposes.
Management has broad discretion over use of funds, which may not enhance results or stock price.
- TimeTickerHeadlineOpen
- VF
Underlying EBIT up 81% to SEK 30.9 bn; profit down 41% amid divestments and market shifts. - ADDT
Earnings and margins rose, acquisitions accelerated, and outlook remains positive. - NCC
Record profits in core segments, major impairment, dividend maintained, outlook positive. - 7004
Order intake and sales rose, but losses and technical issues led to lower profit forecasts. - KIO
Headline earnings per share expected up 11–23% on higher prices and stable operations. - AAL
2026 copper and diamond guidance lowered, premium iron ore guidance raised, portfolio reshaping ongoing. - VRCI
Revenue rose to $3.8m in FY25, fueled by Tutivia test adoption and expanded US coverage. - SYNC
NAV per share rose 3.6% as late-stage clinical assets and Beacon's uplift drove portfolio gains. - SHEL
$18.5B adjusted earnings, $26.1B free cash flow, and $22B+ shareholder returns in 2025. - CPG
Q1 organic revenue up 7.3%, Vermaat acquired, and 2026 profit growth guidance reaffirmed.
Next Arcadia Biosciences earnings date
Next Arcadia Biosciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)